ASP Isotopes Inc. (NASDAQ:ASPI) Short Interest Update

ASP Isotopes Inc. (NASDAQ:ASPI) was the recipient of a large growth in short interest in January. As of January 15th, there was short interest totalling 6,770,000 shares, a growth of 13.8% from the December 31st total of 5,950,000 shares. Currently, 14.6% of the company’s stock are sold short. Based on an average daily volume of 5,090,000 shares, the days-to-cover ratio is currently 1.3 days.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on ASPI shares. Canaccord Genuity Group reissued a “buy” rating and issued a $4.50 price objective on shares of ASP Isotopes in a research report on Friday, October 18th. Canaccord Genuity Group initiated coverage on ASP Isotopes in a research note on Friday, October 4th. They issued a “buy” rating and a $4.50 price target on the stock.

Institutional Trading of ASP Isotopes

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. BNP PARIBAS ASSET MANAGEMENT Holding S.A. purchased a new stake in ASP Isotopes in the 3rd quarter valued at $6,249,000. Telemark Asset Management LLC acquired a new stake in shares of ASP Isotopes during the third quarter worth about $4,726,000. Philadelphia Financial Management of San Francisco LLC grew its holdings in shares of ASP Isotopes by 158.3% during the third quarter. Philadelphia Financial Management of San Francisco LLC now owns 991,863 shares of the company’s stock worth $2,757,000 after buying an additional 607,893 shares during the last quarter. Marshall Wace LLP increased its position in ASP Isotopes by 389.6% in the 2nd quarter. Marshall Wace LLP now owns 545,072 shares of the company’s stock valued at $1,668,000 after acquiring an additional 433,734 shares during the period. Finally, GSA Capital Partners LLP raised its stake in ASP Isotopes by 96.0% during the 3rd quarter. GSA Capital Partners LLP now owns 770,989 shares of the company’s stock valued at $2,143,000 after acquiring an additional 377,721 shares during the last quarter. Institutional investors and hedge funds own 16.80% of the company’s stock.

ASP Isotopes Stock Down 6.2 %

Shares of NASDAQ ASPI traded down $0.38 during mid-day trading on Friday, reaching $5.75. The company had a trading volume of 2,223,383 shares, compared to its average volume of 2,045,652. The firm has a 50 day simple moving average of $5.15 and a two-hundred day simple moving average of $4.26. ASP Isotopes has a 52-week low of $1.86 and a 52-week high of $9.33. The company has a current ratio of 7.55, a quick ratio of 7.54 and a debt-to-equity ratio of 0.80. The stock has a market cap of $410.49 million, a P/E ratio of -9.43 and a beta of 3.48.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.